| Missing Links? Citation Matrix | Graphs | Glossary HistCite Guide About |
Nodes: 407,
Authors: 2208,
Journals: 162,
Outer References: 7145,
Words: 1090
Collection span: 2003 - 2005
View: Overview. Sorted by journal name.
Page 1: 1 2
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
|---|---|---|---|---|---|
| 1 | 2 | 12 | 1 2003 ACTA BIOCHIMICA ET BIOPHYSICA SINICA 35(8):774-778 Yu H; Yang Y; Zhang W; Xie YH; Qin J; et al. Expression and purification of recombinant SARS coronavirus spike protein | 1 | 1 |
| 2 | 1 | 13 | 91 2004 ACTA BIOCHIMICA ET BIOPHYSICA SINICA 36(1):37-41 Zhao P; Ke JS; Qin ZL; Ren H; Zhao LJ; et al. DNA vaccine of SARS-Cov S gene induces antibody response in mice | 4 | 4 |
| 3 | 7 | 33 | 92 2004 ACTA BIOCHIMICA ET BIOPHYSICA SINICA 36(8):541-547 Liu H; Ding YL; Han W; Liu MY; Tian RY; et al. Recombinant scFv antibodies against E protein and N protein of severe acute respiratory syndrome virus | 0 | 0 |
| 4 | 2 | 22 | 93 2004 ACTA BIOCHIMICA POLONICA 51(4):983-993 Blaewicz J; Figlerowicz M; Formanowicz P; Kasprzak M; Nowierski B; et al. Assembling the SARS-CoV genome - new method based on graph theoretical approach | 0 | 0 |
| 5 | 1 | 18 | 94 2004 ACTA CHIMICA SINICA 62(6):542-549 Zheng KW; Yu QS; Wang YH; Zhang B; Hu GX Electrostatic and hydrophobic interactions in SARS coronavirus main proteinase dimer | 0 | 1 |
| 6 | 3 | 15 | 95 2004 ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY 60:2377-2379 Xu YH; Su N; Qin L; Bai ZH; Gao GF; et al. Crystallization and preliminary crystallographic analysis of the heptad-repeat complex of SARS coronavirus spike protein | 0 | 0 |
| 7 | 3 | 14 | 2 2003 ACTA PHARMACOLOGICA SINICA 24(8):741-745 Hu LD; Zheng GY; Jiang HS; Xia Y; Zhang Y; et al. Mutation analysis of 20 SARS virus genome sequences: evidence for negative selection in replicase ORF1b and spike gene | 0 | 2 |
| 8 | 2 | 20 | 3 2003 ACTA PHARMACOLOGICA SINICA 24(10):1051-1059 Cai QC; Jaing QW; Zhao GM; Guo Q; Cao GW; et al. Putative caveolin-binding sites in SARS-CoV proteins | 0 | 0 |
| 9 | 2 | 19 | 96 2004 AMERICAN JOURNAL OF CLINICAL PATHOLOGY 121(4):574-580 Chow KC; Hsiao CH; Lin TY; Chen CL; Chiou SH Detection of severe acute respiratory syndrome-associated coronavirus in pneumocytes of the lung | 4 | 7 |
| 10 | 2 | 23 | 97 2004 AMERICAN JOURNAL OF MEDICINE 117(4):249-254 Chau TN; Lee PO; Choi KW; Lee CM; Ma KF; et al. Value of initial chest radiographs for predicting clinical outcomes in patients with severe acute respiratory syndrome | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 11 | 1 | 21 | 4 2003 AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 168(4):417-424 Tsang KW; Lam WK Management of severe acute respiratory syndrome: The Hong Kong university experience | 4 | 12 |
| 12 | 2 | 16 | 5 2003 ANNALS OF INTERNAL MEDICINE 139(7):564-567 Ho AS; Sung JJY; Chan-Yeung M An outbreak of severe acute respiratory syndrome among hospital workers in a community hospital in Hong Kong | 2 | 15 |
| 13 | 2 | 21 | 98 2004 ANNALS OF INTERNAL MEDICINE 140(8):614-619 Rainer TH; Chan PKS; Ip M; Lee N; Hui DS; et al. The spectrum of severe acute respiratory syndrome-associated coronavirus infection | 0 | 8 |
| 14 | 1 | 9 | 6 2003 ANNALS OF SAUDI MEDICINE 23(3-4):116-117 Al-Hajjar S SARS: Challenge of the new century | 0 | 0 |
| 15 | 2 | 79 | 99 2004 ANNUAL REVIEW OF MEDICINE 55:191-207 Dodd RY; Leiby DA Emerging infectious threats to the blood supply | 0 | 3 |
| 16 | 3 | 12 | 365 2005 ANTIVIRAL RESEARCH 65(1):45-48 Wu CJ; Huang HW; Liu CY; Hong CF; Chan YL Inhibition of SARS-CoV replication by siRNA | 0 | 0 |
| 17 | 51 | 105 | 366 2005 ANTIVIRAL RESEARCH 65(2):69-78 Tan YJ; Lim SG; Hong WJ Characterization of viral proteins encoded by the SARS-coronavirus genome | 0 | 0 |
| 18 | 2 | 10 | 367 2005 APPLIED MATHEMATICS AND COMPUTATION 162(2):909-924 Zhang J; Lou H; Ma Z; Wu JH A compartmental model for the analysis of SARS transmission patterns and outbreak control measures in China | 0 | 0 |
| 19 | 6 | 152 | 100 2004 ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE 128(12):1337-1345 Kiechle FL; Zhang XB; Holland-Staley CA The -omics era and its impact | 0 | 0 |
| 20 | 5 | 41 | 101 2004 ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE 128(12):1346-1350 Mazzulli T; Kain K; Butany J Severe acute respiratory syndrome - Overview with an emphasis, on the Toronto experience | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 21 | 1 | 10 | 102 2004 ARCHIVES OF VIROLOGY 149(3):621-624 Gibbs AJ; Gibbs MJ; Armstrong JS The phylogeny of SARS coronavirus | 3 | 3 |
| 22 | 5 | 38 | 368 2005 ARCHIVES OF VIROLOGY 150(1):1-20 Zhang XW; Yap YL; Danchin A Testing the hypothesis of a recombinant origin of the SARS-associated coronavirus | 0 | 0 |
| 23 | 2 | 16 | 103 2004 ATMOSPHERIC ENVIRONMENT 38(23):3879-3884 Agranovski IE; Safatov AS; Pyankov OV; Sergeev AN; Agafonov AP; et al. Monitoring of viable airborne SARS virus in ambient air | 0 | 1 |
| 24 | 2 | 108 | 7 2003 AVIAN PATHOLOGY 32(6):567-582 Cavanagh D Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus | 5 | 11 |
| 25 | 3 | 22 | 8 2003 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 310(1):78-83 Spiga O; Bernini A; Ciutti A; Chiellini S; Menciassi N; et al. Molecular modelling of S1 and S2 subunits of SARS coronavirus spike glycoprotein | 13 | 16 |
| 26 | 2 | 15 | 9 2003 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 311(4):870-876 He RT; Leeson A; Andonov A; Li Y; Bastien N; et al. Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein | 7 | 11 |
| 27 | 3 | 10 | 10 2003 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 312(4):1159-1164 Xiao XD; Chakraborti S; Dimitrov AS; Gramatikoff K; Dimitrov DS The SARS-CoV S glycoprotein: expression and functional characterization | 29 | 42 |
| 28 | 3 | 14 | 11 2003 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 312(4):1290-1296 Lau LT; Fung YWW; Wong FPF; Lin SSW; Wang CR; et al. A real-time PCR for SARS-coronavirus incorporating target gene pre-amplification | 2 | 7 |
| 29 | 2 | 26 | 104 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 313(4):938-947 Ho TY; Wu SL; Cheng SE; Wei YC; Huang SP; et al. Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein | 5 | 6 |
| 30 | 4 | 19 | 105 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 315(2):439-444 Wang PG; Chen J; Zheng AH; Nie YC; Shi XL; et al. Expression cloning of functional receptor used by SARS coronavirus | 14 | 19 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 31 | 3 | 29 | 106 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 316(2):476-483 He RT; Dobie F; Ballantine M; Leeson A; Li Y; et al. Analysis of multimerization of the SARS coronavirus nucleocapsid protein | 3 | 6 |
| 32 | 3 | 20 | 107 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 317(4):1030-1036 Surjit M; Liu BP; Kumar P; Chow VTK; Lal SK The nucleocapsid protein of the SARS coronavirus is capable of self-association through a C-terminal 209 amino acid interaction domain | 4 | 4 |
| 33 | 5 | 25 | 108 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 318(3):719-725 Yamamoto N; Yang RG; Yoshinaka Y; Amari S; Nakano T; et al. HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus | 4 | 5 |
| 34 | 4 | 26 | 109 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 318(4):833-838 Ho Y; Lin PH; Liu CYY; Lee SP; Chao YC Assembly of human severe acute respiratory syndrome coronavirus-like particles | 2 | 3 |
| 35 | 6 | 21 | 110 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 318(4):862-867 Kuo CJ; Chi YH; Hsu JTA; Liang PH Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate | 3 | 7 |
| 36 | 3 | 37 | 111 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 319(1):283-288 Zhu JQ; Xiao GF; Xu YH; Yuan F; Zheng CY; et al. Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors | 6 | 8 |
| 37 | 7 | 34 | 112 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 319(3):746-752 Yuan KH; Yi L; Chen J; Qu XX; Qing TT; et al. Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein | 2 | 2 |
| 38 | 6 | 16 | 113 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 319(3):929-935 Hua RH; Zhou YJ; Wang YF; Hua YZ; Tong GZ Identification of two antigenic epitopes on SARS-CoV spike protein | 0 | 1 |
| 39 | 13 | 23 | 114 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 319(4):1216-1221 Hofmann H; Geier M; Marzi A; Krumbiegel M; Peipp M; et al. Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor | 2 | 2 |
| 40 | 4 | 33 | 115 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 319(4):1228-1234 Mizutani T; Fukushi S; Saijo M; Kurane I; Morikawa S Phosphorylation of p38 MAPK and its downstream targets in SARS coronavirus-infected cells | 3 | 3 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 41 | 8 | 23 | 116 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 320(4):1199-1203 He RT; Adonov A; Traykova-Adonova M; Cao JX; Cutts T; et al. Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid | 0 | 1 |
| 42 | 7 | 47 | 117 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 321(3):557-565 Luo C; Luo HB; Zheng SX; Gui CS; Yue LD; et al. Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A | 1 | 1 |
| 43 | 4 | 29 | 118 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 321(4):994-1000 Nie YC; Wang PG; Shi XL; Wang GW; Chen J; et al. Highly infectious SARS-CoV pseudotyped virus reveals the cell tropism and its correlation with receptor expression | 0 | 1 |
| 44 | 4 | 28 | 119 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 323(1):264-268 Keyaerts E; Vijgen L; Maes P; Neyts J; Van Ranst M In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine | 0 | 0 |
| 45 | 7 | 11 | 120 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 324(2):579-583 Shan YF; Li SF; Xu GJ A novel auto-cleavage assay for studying mutational effects on the active site of severe acute respiratory syndrome coronavirus 3C-like protease | 0 | 0 |
| 46 | 5 | 19 | 121 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 324(2):761-767 Hsu CH; Ko TP; Yu HM; Tang TK; Chen ST; et al. Immunological, structural, and preliminary X-ray diffraction characterizations of the fusion core of the SARS-coronavirus spike protein | 1 | 1 |
| 47 | 17 | 58 | 122 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 324(2):773-781 He YX; Zhou YS; Liu SW; Kou ZH; Li WH; et al. Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine | 2 | 3 |
| 48 | 4 | 37 | 123 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 324(4):1186-1193 Qin ZL; Zhao P; Zhang XL; Yu JG; Cao MM; et al. Silencing of SARS-CoV spike gene by small interfering RNA in HEK 293T cells | 0 | 0 |
| 49 | 1 | 20 | 124 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 325(1):374-380 Liao Y; Lescar J; Tam JP; Liu DX Expression of SARS-coronavirus envelope protein in Escherichia coli cells alters membrane permeability | 1 | 1 |
| 50 | 19 | 36 | 125 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 325(2):445-452 He YX; Zhou YS; Siddiqui P; Jiang SB Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 51 | 16 | 38 | 369 2005 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 326(3):554-563 Bergeron E; Vincent MJ; Wickham L; Hamelin J; Basak A; et al. Implication of proprotein convertases in the processing and spread of severe acute respiratory syndrome coronavirus | 0 | 0 |
| 52 | 18 | 31 | 370 2005 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 327(1):130-135 Wang ZJ; Yuan ZH; Matsumoto M; Hengge UR; Chang YF Immune responses with DNA vaccines encoded different gene fragments of severe acute respiratory syndrome coronavirus in BALB/c mice | 0 | 0 |
| 53 | 7 | 13 | 126 2004 BIOCHEMICAL JOURNAL 383:13-18 Surjit M; Liu BP; Jameel S; Chow VTK; Lal SK The SARS coronavirus nucleocapsid protein induces actin reorganization and apoptosis in COS-1 cells in the absence of growth factors | 0 | 1 |
| 54 | 5 | 33 | 127 2004 BIOCHEMISTRY 43(15):4568-4574 Huang CK; Wei P; Fan KQ; Liu Y; Lai LH 3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism | 5 | 7 |
| 55 | 4 | 33 | 128 2004 BIOCHEMISTRY 43(20):6059-6063 Huang QL; Yu LP; Petros AM; Gunasekera A; Liu ZH; et al. Structure of the N-terminal RNA-binding domain of the SARS CoV nucleocapsid protein | 4 | 5 |
| 56 | 3 | 32 | 129 2004 BIOCHEMISTRY 43(34):11103-11108 Wang YL; Wu XY; Wang YH; Li B; Zhou H; et al. Low stability of nucleocapsid protein in SARS virus | 0 | 0 |
| 57 | 4 | 32 | 130 2004 BIOCHEMISTRY 43(44):14064-14071 Xu YH; Zhu JQ; Liu YW; Lou ZY; Yuan F; et al. Characterization of the heptad repeat regions, HR1 and HR2, and design of a fusion core structure model of the spike protein from severe acute respiratory syndrome (SARS) coronavirus | 0 | 0 |
| 58 | 14 | 55 | 131 2004 BIOCHEMISTRY 43(47):14958-14970 Chou CY; Chang HC; Hsu WC; Lin TZ; Lin CH; et al. Quaternary structure of the severe acute respiratory syndrome (SARS) coronavirus main protease | 0 | 0 |
| 59 | 5 | 83 | 371 2005 BIOCHEMISTRY 44(3):947-958 Sainz B; Rausch JM; Gallaher WR; Garry RF; Wimley WC The aromatic domain of the coronavirus class I viral fusion protein induces membrane permeabilization: Putative role during viral entry | 0 | 0 |
| 60 | 15 | 47 | 372 2005 BIOCHEMISTRY 44(5):1453-1463 Yu CY; Gui CS; Luo HB; Chen LL; Zhang L; et al. Folding of the SARS coronavirus spike glycoprotein immunological fragment (SARS-S1B): Thermodynamic and kinetic investigation correlating with three-dimensional structural modeling | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 61 | 4 | 30 | 132 2004 BIOLOGY OF THE NEONATE 85(4):293-298 Ng PC; Leung CW; Chiu WK; Wong SF; Hon EKL SARS in newborns and children | 0 | 0 |
| 62 | 2 | 14 | 12 2003 BIOMEDICAL AND ENVIRONMENTAL SCIENCES 16(3):246-255 Duan SM; Zhao XS; Wen RF; Huang JJ; Pi GH; et al. Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation | 2 | 4 |
| 63 | 4 | 38 | 133 2004 BIOPHYSICAL CHEMISTRY 112(1):15-25 Luo HB; Ye F; Sun T; Yue LD; Peng SY; et al. In vitro biochemical and thermodynamic characterization of nucleocapsid protein of SARS | 0 | 0 |
| 64 | 3 | 32 | 373 2005 BIOPHYSICAL JOURNAL 88(2):1283-1290 Torres J; Wang JF; Parthasarathy K; Liu DX The transmembrane oligomers of coronavirus protein E | 0 | 0 |
| 65 | 2 | 65 | 134 2004 BLOOD 104(1):200-206 Wang BM; Chen HB; Jiang XD; Zhang MH; Wan T; et al. Identification of an HLA-A*0201-restricted CD8(+) T-cell epitope SSp-1 of SARS-CoV spike protein | 0 | 0 |
| 66 | 2 | 28 | 13 2003 BMC BIOINFORMATICS 4 Yap YL; Zhang XW; Danchin A Relationship of SARS-CoV to other pathogenic RNA viruses explored by tetranucleotide usage profiling | 0 | 1 |
| 67 | 3 | 16 | 135 2004 BMC BIOINFORMATICS 5 Pavlovic-Lazetic GM; Mitic NS; Beljanski MV Bioinformatics analysis of SARS coronavirus genome polymorphism | 0 | 0 |
| 68 | 6 | 39 | 136 2004 BMC BIOINFORMATICS 5 Kiemer L; Lund O; Brunak S; Blom N Coronavirus 3CL(pro) proteinase cleavage sites: Possible relevance to SARS virus pathology | 0 | 1 |
| 69 | 3 | 37 | 137 2004 BMC EVOLUTIONARY BIOLOGY 4 Zhao ZM; Li HP; Wu XZ; Zhong YX; Zhang KQ; et al. Moderate mutation rate in the SARS coronavirus genome and its implications | 0 | 1 |
| 70 | 2 | 10 | 138 2004 BMC INFECTIOUS DISEASES 4 Lu HC; Zhao Y; Zhang JF; Wang YL; Li W; et al. Date of origin of the SARS coronavirus strains | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 71 | 5 | 42 | 139 2004 BMC INFECTIOUS DISEASES 4 Ng LF; Hibberd ML; Ooi EE; Tang KF; Neo SY; et al. A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infection | 0 | 1 |
| 72 | 3 | 16 | 140 2004 BMC INFECTIOUS DISEASES 4 Vega VB; Ruan YJ; Liu JJ; Lee WH; Wei CL; et al. Mutational dynamics of the SARS coronavirus in cell culture and human populations isolated in 2003 | 0 | 0 |
| 73 | 7 | 28 | 374 2005 BMC INFECTIOUS DISEASES 5 Moes E; Vijgen L; Keyaerts E; Zlateva K; Li S; et al. A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium | 0 | 0 |
| 74 | 2 | 23 | 14 2003 BMC MICROBIOLOGY 3 Kliger Y; Levanon EY Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy | 0 | 9 |
| 75 | 1 | 11 | 15 2003 BRITISH DENTAL JOURNAL 195(10):557-561 Smales FC; Samaranyake LP Maintaining dental education and specialist dental care during an outbreak of a new coronavirus infection. Part 1: A deadly viral epidemic begins | 0 | 0 |
| 76 | 1 | 36 | 141 2004 BRITISH DENTAL JOURNAL 197(2):77-80 Li RWK; Leung KWC; Sun FCS; Samaranayake LP Severe Acute Respiratory Syndrome (SARS) and the GDP. Part I : Epidemiology, virology, pathology and general health issues | 0 | 0 |
| 77 | 2 | 3 | 142 2004 BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE 137(2):197-199 Onishchenko GG; Govorun VM; Sergienko VI; Akopian TA; Momynaliev KT; et al. Structural organization of the genome of SARS-associated coronavirus (strain SoD) isolated on the territory of the Russian Federation | 0 | 0 |
| 78 | 3 | 7 | 16 2003 BULLETIN OF THE KOREAN CHEMICAL SOCIETY 24(7):899-900 Reddy AD; Suh SB; Ghaffari R; Singh NJ; Kim DJ; et al. Bioinformatics analysis of SARS proteins and molecular dynamics simulated structure of an alpha-helix motif | 0 | 1 |
| 79 | 1 | 30 | 17 2003 CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE 50(10):989-997 Peng PWH; Wong DT; Bevan D; Gardam M Infection control and anesthesia: Lessons learned from the Toronto SARS outbreak | 0 | 2 |
| 80 | 2 | 20 | 143 2004 CANADIAN MEDICAL ASSOCIATION JOURNAL 170(1):47-54 Tang P; Louie M; Richardson SE; Smieja M; Simor AE; et al. Interpretation of diagnostic laboratory tests for severe acute respiratory syndrome: the Toronto experience | 7 | 17 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 81 | 3 | 8 | 18 2003 CELL 115(6):652-653 Dimitrov DS The secret life of ACE2 as a receptor for the SARS virus | 8 | 11 |
| 82 | 16 | 27 | 144 2004 CELLULAR AND MOLECULAR LIFE SCIENCES 61(19-20):2428-2430 Xiao X; Dimitrov DS The SARS-CoV S glycoprotein | 0 | 0 |
| 83 | 13 | 66 | 145 2004 CELLULAR AND MOLECULAR LIFE SCIENCES 61(21):2738-2743 Kuhn JH; Li W; Choe H; Farzan M Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus | 0 | 0 |
| 84 | 4 | 19 | 146 2004 CHEMICAL & PHARMACEUTICAL BULLETIN 52(5):643-645 Takeda-Shitaka M; Nojima H; Takaya D; Kanou K; Iwadate M; et al. Evaluation of homology modeling of the severe acute respiratory syndrome (SARS) coronavirus main protease for structure based drug design | 2 | 3 |
| 85 | 2 | 9 | 19 2003 CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE 24(12):2279-2281 Gao XF; Xi Z; Huang XR; Sun CC 3D modeling of SARS virus proteinase and study of imaginable peptide inhibitor | 0 | 0 |
| 86 | 2 | 21 | 375 2005 CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE 26(1):55-60 Zheng KW; Yu QS; Jiang YJ; Ma GZ; Zhao WN; et al. Effects of electrostatic and hydrophobic interaction on the stability of SARS coronavirus 3CL proteinase dimer | 0 | 0 |
| 87 | 3 | 25 | 376 2005 CHEMICAL PHYSICS LETTERS 401(1-3):24-29 Liu HL; Lin JC; Ho Y; Chen CW Homology models of main proteinase from coronavirus associated with SARS | 0 | 0 |
| 88 | 11 | 26 | 147 2004 CHEMISTRY & BIOLOGY 11(9):1293-1299 Kao RY; Tsui WHW; Lee TSW; Tanner JA; Watt RM; et al. Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics | 2 | 2 |
| 89 | 10 | 52 | 148 2004 CHEMISTRY & BIOLOGY 11(10):1445-1453 Blanchard JE; Elowe NH; Huitema C; Fortin PD; Cechetto JD; et al. High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase | 0 | 0 |
| 90 | 12 | 53 | 149 2004 CHEST 126(3):670-674 Hui DSC; Sung JJY Treatment of severe acute respiratory syndrome | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 91 | 2 | 6 | 150 2004 CHINESE JOURNAL OF ANALYTICAL CHEMISTRY 32(4):415-420 Zhang YJ; Wang JL; Cai Y; Ying WT; Hao YW; et al. Studies on structural proteins of severe acute respiratory syndrome-coronavirus by liquid chromatography coupled with electrospray ionization-quadrupole time-of-flight tandem mass spectrometry | 0 | 0 |
| 92 | 2 | 9 | 20 2003 CHINESE MEDICAL JOURNAL 116(6):811-818 Wu W; Wang JF; Liu PM; Chen WX; Yin SM; et al. A hospital outbreak of severe acute respiratory syndrome in Guangzhou, China | 2 | 11 |
| 93 | 1 | 6 | 21 2003 CHINESE MEDICAL JOURNAL 116(7):988-990 Wu XW; Cheng G; Di B; Yin AH; He YS; et al. Establishment of a fluorescent polymerase chain reaction method for the detection of the SARS-associated coronavirus and its clinical application | 0 | 7 |
| 94 | 2 | 28 | 22 2003 CHINESE MEDICAL JOURNAL 116(9):1288-1292 Li LJ; Wang ZG; Lu YY; Bao QY; Chen SH; et al. Severe acute respiratory syndrome-associated coronavirus genotype and its characterization | 3 | 5 |
| 95 | 2 | 64 | 23 2003 CHINESE MEDICAL JOURNAL 116(11):1603-1636 [Anon] Consensus for the management of severe acute respiratory syndrome | 0 | 0 |
| 96 | 7 | 18 | 151 2004 CHINESE MEDICAL JOURNAL 117(1):42-48 Wang ZG; Li LJ; Luo Y; Zhang JY; Wang MY; et al. Molecular biological analysis of genotyping and phylogeny of severe acute respiratory syndrome associated coronavirus | 1 | 1 |
| 97 | 10 | 23 | 152 2004 CHINESE MEDICAL JOURNAL 117(11):1625-1629 Zhang CH; Guo ZM; Zheng HY; Lu JH; Wang YF; et al. Humoral immune responses in rabbits induced by an experimental inactivated severe acute respiratory syndrome coronavirus vaccine prepared from F69 strain | 0 | 0 |
| 98 | 2 | 8 | 24 2003 CHINESE SCIENCE BULLETIN 48(12):1165-1169 Shi R; Ma WL; Wu QH; Zhang B; Song YB; et al. Design and application of 60mer oligonucleotide microarray in SARS coronavirus detection | 0 | 0 |
| 99 | 1 | 8 | 25 2003 CHINESE SCIENCE BULLETIN 48(12):1170-1174 Gao L; Qi J; Wei HB; Sun YG; Hao BL Molecular phylogeny of coronaviruses including human SARS-CoV | 1 | 3 |
| 100 | 2 | 15 | 26 2003 CHINESE SCIENCE BULLETIN 48(12):1175-1178 Qi Z; Hu Y; Li W; Chen YJ; Zhang ZH; et al. Phylogeny of SARS-CoV as inferred from complete genome comparison | 2 | 2 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 101 | 2 | 26 | 27 2003 CHINESE SCIENCE BULLETIN 48(13):1277-1287 Liu SQ; Guo T; Li XL; Sun ZR Bioinformatical study on the proteomics and evolution of SARS-CoV | 1 | 3 |
| 102 | 2 | 19 | 28 2003 CHINESE SCIENCE BULLETIN 48(23):2621-2625 Tang L; Wang J; Qin E; Zhu QY; Yu M; et al. Preparation, characterization and preliminary in vivo studies of inactivated SARS-CoV vaccine | 1 | 1 |
| 103 | 2 | 15 | 153 2004 CHINESE SCIENCE BULLETIN 49(6):585-590 Jin WW; Chen C; Zhang Y; Zhao YQ; Feng JD; et al. Genome sequencing and characterization analysis of a Beiffing isolate of chicken coronavirus infectious bronchitis virus | 1 | 1 |
| 104 | 8 | 25 | 154 2004 CHINESE SCIENCE BULLETIN 49(12):1311-1313 Zhang Y; Zheng N; Hao P; Zhong Y Reconstruction of the most recent common ancestor sequences of SARS-Cov S gene and detection of adaptive evolution in the spike protein | 0 | 0 |
| 105 | 10 | 13 | 155 2004 CHINESE SCIENCE BULLETIN 49(17):1824-1827 Jin WW; Hu LX; Du ZL; Gao Q; Gao H; et al. Genome sequence variation analysis of two SARS coronavirus isolates after passage in Vero cell culture | 0 | 0 |
| 106 | 1 | 9 | 156 2004 CHINESE SCIENCE BULLETIN 49(19):2037-2040 Mei H; Sun LL; Zhou Y; Xiong Q; Li ZL Identification of encoding proteins related to SARS-CoV | 0 | 0 |
| 107 | 4 | 14 | 157 2004 CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY 11(2):287-291 Guan M; Chen HY; Foo SY; Tan YJ; Goh PY; et al. Recombinant protein-based enzyme-linked immunosorbent assay and immunochromatographic tests for detection of immunoglobulin G antibodies to severe acute respiratory syndrome (SARS) coronavirus in SARS patients | 6 | 7 |
| 108 | 5 | 16 | 158 2004 CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY 11(2):362-371 Tan YJ; Goh PY; Fielding BC; Shen S; Chou CF; et al. Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers | 6 | 8 |
| 109 | 3 | 19 | 159 2004 CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY 11(2):417-422 He QG; Chong KH; Chng HH; Leung B; Ling AE; et al. Development of a Western blot assay for detection of antibodies against coronavirus causing severe acute respiratory syndrome | 3 | 3 |
| 110 | 4 | 14 | 160 2004 CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY 11(4):699-703 Guan M; Chan KH; Peiris JSM; Kwan SW; Lam SY; et al. Evaluation and validation of an enzyme-linked immunosorbent assay and an immunochromatographic test for serological diagnosis of severe acute respiratory syndrome | 1 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 111 | 10 | 22 | 161 2004 CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY 11(6):1148-1153 Ming G; Hsiao YC; Tan PH; Shuo S; Goh PY; et al. Use of viral lysate antigen combined with recombinant protein in western immunoblot assay as confirmatory test for serodiagnosis of severe acute respiratory syndrome | 0 | 0 |
| 112 | 3 | 46 | 162 2004 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 136(1):95-103 Wong CK; Lam CWK; Wu AKL; Ip WK; Lee NLS; et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome | 8 | 17 |
| 113 | 3 | 18 | 377 2005 CLINICAL AND LABORATORY HAEMATOLOGY 27(1):15-20 Chng J; Lai HC; Earnest A; Kuperan P Haematological parameters in severe acute respiratory syndrome | 0 | 0 |
| 114 | 3 | 11 | 29 2003 CLINICAL CHEMISTRY 49(12):1976-1980 Ng EKO; Hui DS; Chan KCA; Hung ECW; Chiu RWK; et al. Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome | 12 | 24 |
| 115 | 2 | 14 | 30 2003 CLINICAL CHEMISTRY 49(12):1989-1996 Wang JQ; Wen J; Li JX; Yin JN; Zhu QY; et al. Assessment of immunoreactive synthetic peptides from the structural proteins of severe acute respiratory syndrome coronavirus | 10 | 14 |
| 116 | 3 | 18 | 163 2004 CLINICAL CHEMISTRY 50(1):67-72 Poon LLM; Chan KH; Wong OK; Cheung TKW; Ng I; et al. Detection of SARS coronavirus in patients with severe acute respiratory syndrome by conventional and real-time quantitative reverse transcription-PCR assays | 3 | 11 |
| 117 | 3 | 12 | 164 2004 CLINICAL CHEMISTRY 50(1):231-233 Chim SSC; Tong YK; Hung ECW; Chiu RWK; Lo YMD Genomic Sequencing of a SARS coronavirus isolate that predated the Metropole Hotel case cluster in Hong Kong | 0 | 1 |
| 118 | 3 | 27 | 165 2004 CLINICAL CHEMISTRY 50(6):988-995 Chen ZL; Pei DC; Jiang LX; Song YJ; Wang J; et al. Antigenicity analysis of different regions of the severe acute respiratory syndrome coronavirus nucleocapsid protein | 1 | 2 |
| 119 | 4 | 16 | 166 2004 CLINICAL CHEMISTRY 50(6):1036-1042 Choy WY; Lin SG; Chan PKS; Tam JSL; Lo YMD; et al. Synthetic peptide studies on the severe acute respiratory syndrome (SARS) coronavirus spike glycoprotein: Perspective for SARS vaccine development | 1 | 1 |
| 120 | 3 | 13 | 167 2004 CLINICAL CHEMISTRY 50(7):1237-1240 Wang HB; Mao YL; Ju LC; Zhang J; Liu ZG; et al. Detection and monitoring of SARS coronavirus in the plasma and peripheral blood lymphocytes of patients with severe acute respiratory syndrome | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 121 | 6 | 30 | 378 2005 CLINICAL CHEMISTRY 51(1):56-64 Kang XX; Xu Y; Wu XY; Liang Y; Wang C; et al. Proteomic fingerprints for potential application to early diagnosis of severe acute respiratory syndrome | 0 | 0 |
| 122 | 3 | 10 | 168 2004 CLINICAL IMMUNOLOGY 113(2):151-154 Wang YD; Chen WF Detecting specific cytotoxic T lymphocytes against SARS-coronavirus with DimerX HLA-A2 : Ig fusion protein | 1 | 1 |
| 123 | 1 | 234 | 31 2003 CLINICAL INFECTIOUS DISEASES 37(11):1405-1432 Mandell LA; Bartlett JG; Dowell SF; File TM; Musher DM; et al. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults | 0 | 82 |
| 124 | 3 | 18 | 169 2004 CLINICAL INFECTIOUS DISEASES 38(2):297-299 Poon LLM; Chan KH; Peiris JSM Crouching tiger, hidden dragon: The laboratory diagnosis of severe acute respiratory syndrome | 1 | 3 |
| 125 | 2 | 117 | 170 2004 CLINICS IN PERINATOLOGY 31(3):501-+ Lawrence RM; Lawrence RA Breast milk and infection | 0 | 0 |
| 126 | 3 | 27 | 32 2003 CRITICAL CARE MEDICINE 31(11):2684-2692 Manocha S; Walley KR; Russell JA Severe acute respiratory distress syndrome (SARS): A critical care perspective | 3 | 5 |
| 127 | 4 | 60 | 171 2004 CURRENT MEDICINAL CHEMISTRY 11(5):551-558 Takeda-Shitaka M; Takaya D; Chiba C; Tanaka H; Umeyama H Protein structure prediction in structure based drug design | 1 | 2 |
| 128 | 2 | 37 | 33 2003 CURRENT OPINION IN BIOTECHNOLOGY 14(6):641-646 Kuiken T; Fouchier R; Rimmelzwaan G; Osterhaus A Emerging viral infections in a rapidly changing world | 0 | 1 |
| 129 | 5 | 34 | 34 2003 CURRENT OPINION IN INFECTIOUS DISEASES 16(6):565-571 Davidson A; Siddell S Potential for antiviral treatment of severe acute respiratory syndrome | 1 | 6 |
| 130 | 2 | 38 | 172 2004 CURRENT OPINION IN INFECTIOUS DISEASES 17(2):143-148 Wang JT; Chang SC Severe acute respiratory syndrome | 0 | 2 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 131 | 25 | 61 | 173 2004 CURRENT OPINION IN MICROBIOLOGY 7(4):412-419 Ziebuhr J Molecular biology of severe acute respiratory syndrome coronavirus | 0 | 1 |
| 132 | 4 | 78 | 174 2004 CURRENT OPINION IN PEDIATRICS 16(1):61-69 Keeler N; Lingappa J Severe acute respiratory syndrome: public health response and clinical practice update for an emerging disease | 0 | 0 |
| 133 | 2 | 9 | 175 2004 CURRENT SCIENCE 86(6):842-844 Singh AN; Gupta D; Jameel S Bioinformatic analysis of the SARS virus X1 protein shows it to be a calcium-binding protein | 0 | 0 |
| 134 | 2 | 42 | 379 2005 DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY 29(2):153-160 Pei JW; Collisson EW Specific antibody secreting cells from chickens can be detected by three days and memory B cells by three weeks post-infection with the avian respiratory coronavirus | 0 | 0 |
| 135 | 2 | 20 | 176 2004 DNA AND CELL BIOLOGY 23(6):391-394 Tang L; Zhu QY; Qin E; Yu M; Ding ZF; et al. Inactivated SARS-CoV vaccine prepared from whole virus induces a high level of neutralizing antibodies in BALB/c mice | 3 | 3 |
| 136 | 4 | 83 | 177 2004 DRUG DISCOVERY TODAY 9(15):659-669 Hillisch A; Pineda LF; Hilgenfeld R Utility of homology models in the drug discovery process | 0 | 1 |
| 137 | 2 | 16 | 35 2003 EMERGING INFECTIOUS DISEASES 9(9):1037-1041 Breiman RF; Evans MR; Preiser W; Maguire J; Schnur A; et al. Role of China in the quest to define and control severe acute respiratory syndrome | 7 | 14 |
| 138 | 2 | 11 | 178 2004 EMERGING INFECTIOUS DISEASES 10(2):179-184 Weingartl HM; Copps J; Drebot MA; Marszal P; Smith G; et al. Susceptibility of pigs and chickens to SARS coronavirus | 3 | 8 |
| 139 | 1 | 16 | 179 2004 EMERGING INFECTIOUS DISEASES 10(2):311-316 Emery SL; Erdman DD; Bowen MD; Newton BR; Winchell JM; et al. Real-time reverse transcription-polymerase chain reaction assay for SARS-associated coronavirus | 5 | 14 |
| 140 | 4 | 40 | 180 2004 EMERGING INFECTIOUS DISEASES 10(2):320-326 Goldsmith CS; Tatti KM; Ksiazek TG; Rollin PE; Comer JA; et al. Ultrastructural characterization of SARS coronavirus | 4 | 6 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 141 | 2 | 22 | 181 2004 EMERGING INFECTIOUS DISEASES 10(3):413-418 Vicenzi E; Canducci F; Pinna D; Mancini N; Carletti S; et al. Coronaviridae and SARS-associated coronavirus strain HSR1 | 0 | 1 |
| 142 | 2 | 11 | 182 2004 EMERGING INFECTIOUS DISEASES 10(3):530-532 Chan PKS; Ng KC; Chan RCW; Lam RKY; Chow VCY; et al. Immunofluorescence assay for serologic diagnosis of SARS | 2 | 10 |
| 143 | 3 | 16 | 183 2004 EMERGING INFECTIOUS DISEASES 10(5):914-916 Swayne DE; Suarez DL; Spackman E; Tumpey TM; Beck JR; et al. Domestic poultry and SARS coronavirus, southern China | 1 | 1 |
| 144 | 2 | 21 | 184 2004 EMERGING INFECTIOUS DISEASES 10(6):1030-1037 Xu RH; He JF; Evans MR; Peng GW; Field HE; et al. Epidemiologic clues to SARS origin in China | 4 | 9 |
| 145 | 2 | 30 | 185 2004 EMERGING INFECTIOUS DISEASES 10(7):1213-1219 Wang WK; Chen SY; Liu IJ; Chen YC; Chen HL; et al. Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis | 0 | 2 |
| 146 | 3 | 14 | 186 2004 EMERGING INFECTIOUS DISEASES 10(10):1841-1843 Liu W; Tang F; Fontanet A; Zhan L; Zhao QM; et al. Long-term SARS coronavirus excretion from patient cohort, China | 0 | 0 |
| 147 | 3 | 30 | 187 2004 EXPERT OPINION ON BIOLOGICAL THERAPY 4(6):767-772 De Groot AS Immunome-derived vaccines | 0 | 0 |
| 148 | 20 | 79 | 188 2004 EXPERT OPINION ON PHARMACOTHERAPY 5(8):1687-1693 Hui DSC; Wong GWK Advancements in the battle against severe acute respiratory syndrome | 0 | 0 |
| 149 | 2 | 16 | 36 2003 FEBS LETTERS 553(3):451-456 Gao F; Ou HY; Chen LL; Zheng WX; Zhang CT Prediction of proteinase cleavage sites in polyproteins of coronaviruses and its applications in analyzing SARS-CoV genomes | 2 | 4 |
| 150 | 3 | 21 | 37 2003 FEBS LETTERS 554(3):257-263 Yan L; Velikanov M; Flook P; Zheng WJ; Szalma S; et al. Assessment of putative protein targets derived from the SARS genome | 2 | 4 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 151 | 5 | 26 | 189 2004 FEBS LETTERS 565(1-3):111-116 Yu CJ; Chen YC; Hsiao CH; Kuo TC; Chang SC; et al. Identification of a novel protein 3a from severe acute respiratory syndrome coronavirus | 2 | 3 |
| 152 | 6 | 34 | 190 2004 FEBS LETTERS 576(1-2):174-178 Mortola E; Roy P Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system | 0 | 0 |
| 153 | 11 | 22 | 191 2004 FEBS LETTERS 576(3):325-330 Kao RY; To APC; Ng LWY; Tsui WHW; Lee TSW; et al. Characterization of SARS-CoV main protease and identification of biologically active small molecule inhibitors using a continuous fluorescence-based assay | 0 | 0 |
| 154 | 9 | 22 | 192 2004 FEBS LETTERS 577(1-2):159-164 Inberg A; Linial M Evolutional insights on uncharacterized SARS coronavirus genes | 0 | 0 |
| 155 | 5 | 34 | 193 2004 FEBS LETTERS 577(1-2):187-192 Mizutani T; Fukushi S; Murakami M; Hirano T; Saijo M; et al. Tyrosine dephosphorylation of STAT3 in SARS coronavirus-infected Vero E6 cells | 0 | 0 |
| 156 | 1 | 36 | 194 2004 GENOMICS 83(4):541-549 Rockett JC; Hellmann GM Confinning microarray data - is it really necessary? | 0 | 5 |
| 157 | 3 | 21 | 195 2004 HEPATOLOGY 39(2):291-294 Humar A; McGilvray I; Phillips MJ; Levy GA Severe acute respiratory syndrome and the liver | 1 | 1 |
| 158 | 3 | 45 | 196 2004 HEPATOLOGY 39(2):302-310 Chau TN; Lee KC; Yao H; Tsang TY; Chow TC; et al. SARS-associated viral hepatitis caused by a novel coronavirus: Report of three cases | 4 | 6 |
| 159 | 3 | 19 | 197 2004 IMMUNOLOGY LETTERS 92(3):237-243 Zhu MS; Pan Y; Chen HQ; Shen Y; Wang XC; et al. Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine | 5 | 9 |
| 160 | 1 | 82 | 198 2004 IMPACT OF ECOLOGICAL CHANGES ON TROPICAL ANIMAL HEALTH AND DISEASE CONTROL 1026:1-11 Daszak P; Tabor GM; Kilpatrick AM; Epstein J; Plowright R Conservation medicine and a new agenda for emerging diseases | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 161 | 2 | 21 | 199 2004 INFORMS JOURNAL ON COMPUTING 16(4):331-340 Chew DSH; Choi KP; Heidner H; Leung MY Palindromes in SARS and other coronaviruses | 0 | 0 |
| 162 | 8 | 31 | 200 2004 INTERNATIONAL IMMUNOLOGY 16(10):1423-1430 Takasuka N; Fujii H; Takahashi Y; Kasai M; Morikawa S; et al. A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice | 3 | 4 |
| 163 | 5 | 66 | 201 2004 INTERNATIONAL JOURNAL OF EPIDEMIOLOGY 33(4):628-634 Parashar UD; Anderson LJ Severe acute respiratory syndrome: review and lessons of the 2003 outbreak | 0 | 0 |
| 164 | 3 | 13 | 38 2003 INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY 293(4):229-231 Ziebuhr J SARS - Unprecedented global response to a newly emerging disease | 0 | 0 |
| 165 | 2 | 34 | 202 2004 INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 14(2):311-315 Yang M; Li CK; Li K; Hon KLE; Ng MHL; et al. Hematological findings in SARS patients and possible mechanisms (Review) | 0 | 0 |
| 166 | 2 | 31 | 203 2004 INTERNATIONAL JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH 10(4):421-427 Chan-Yeung M Severe acute respiratory syndrome (SARS) and Healthcare workers | 0 | 1 |
| 167 | 5 | 80 | 39 2003 INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE 7(12):1117-1130 Chan-Yeung M; Ooi GC; Hui DS; Ho PL; Tsang KW Severe acute respiratory syndrome | 0 | 1 |
| 168 | 2 | 32 | 204 2004 INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE 8(10):1173-1179 Ho JC; Wu AY; Lam B; Ooi GC; Khong PL; et al. Pentaglobin in steroid-resistant severe acute respiratory syndrome | 0 | 0 |
| 169 | 1 | 25 | 40 2003 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 290(3):374-380 Lew TWK; Kwek TK; Tai D; Earnest A; Loo S; et al. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome | 11 | 38 |
| 170 | 1 | 5 | 41 2003 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 290(20):2665-2666 He ML; Zheng BJ; Peng Y; Peiris JSM; Poon LLM; et al. Inhibition of SARS-associated coronavirus infection and replication by RNA interference | 1 | 4 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 171 | 2 | 19 | 42 2003 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 290(24):3251-3253 Hughes JM The SARS response - Building and assessing an evidence-based approach to future global microbial threats | 0 | 2 |
| 172 | 3 | 24 | 205 2004 JAPANESE JOURNAL OF VETERINARY RESEARCH 52(3):105-112 Kariwa H; Fujii N; Takashima I Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions, and chemical reagents | 0 | 0 |
| 173 | 3 | 50 | 206 2004 JASSS-THE JOURNAL OF ARTIFICIAL SOCIETIES AND SOCIAL SIMULATION 7(4) Huang CY; Sun CT; Hsieh JL; Lin H Simulating SARS: Small-world epidemiological modeling and public health policy assessments | 0 | 0 |
| 174 | 2 | 134 | 207 2004 JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION 224(7):1084-1095 Davis RG The ABCs of bioterrorism for veterinarians, focusing on Category A agents | 0 | 1 |
| 175 | 1 | 28 | 208 2004 JOURNAL OF ADVANCED NURSING 45(6):568-578 Affonso DD; Andrews GJ; Jeffs L The urban geography of SARS: paradoxes and dilemmas in Toronto's health care | 0 | 2 |
| 176 | 1 | 48 | 209 2004 JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE 10(6):1041-1051 Liu JP; Manheimer E; Shi Y; Gluud C Chinese herbal medicine for severe acute respiratory syndrome: A systematic review and meta-analysis | 0 | 0 |
| 177 | 4 | 30 | 43 2003 JOURNAL OF BIOLOGICAL CHEMISTRY 278(41):39578-39582 Tanner JA; Watt RM; Chai YB; Lu LY; Lin MC; et al. The severe acute respiratory syndrome (SARS) coronavirus NTPase/helicase belongs to a distinct class of 5 ' to 3 ' viral helicases | 6 | 9 |
| 178 | 3 | 24 | 210 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(3):1637-1642 Fan KQ; Wei P; Feng Q; Chen SD; Huang CK; et al. Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase | 10 | 18 |
| 179 | 3 | 18 | 211 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(5):3197-3201 Wong SK; Li WH; Moore MJ; Choe H; Farzan M A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2 | 24 | 35 |
| 180 | 6 | 42 | 212 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(23):24765-24773 Shi JH; Wei Z; Song JX Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme - Defining the extra domain as a new target for design of highly specific protease inhibitors | 7 | 8 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 181 | 1 | 51 | 213 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(29):30514-30522 Xu YH; Liu YW; Lou ZY; Qin L; Li X; et al. Structural basis for coronavirus-mediated membrane fusion - Crystal structure of mouse hepatitis virus spike protein fusion core | 6 | 7 |
| 182 | 10 | 51 | 214 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(47):49414-49419 Xu YH; Lou ZY; Liu YW; Pang H; Tien P; et al. Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core | 1 | 1 |
| 183 | 4 | 86 | 44 2003 JOURNAL OF BIOMEDICAL SCIENCE 10(6):664-675 Lai MMC SARS virus: The beginning of the unraveling of a new coronavirus | 2 | 4 |
| 184 | 3 | 17 | 215 2004 JOURNAL OF BIOMEDICAL SCIENCE 11(1):117-126 Wu HS; Hsieh YC; Su IJ; Lin TH; Chiu SC; et al. Early detection of antibodies against various structural proteins of the SARS-associated coronavirus in SARS patients | 0 | 4 |
| 185 | 3 | 8 | 380 2005 JOURNAL OF BIOMOLECULAR NMR 31(1):79-80 Zhong N; Huang Q; Jin C; Xia B H-1, C-13, and N-15 resonance assignments of the N-terminal domain of the SARS CoV nucleocapsid protein | 0 | 0 |
| 186 | 3 | 54 | 216 2004 JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS 22(1):65-77 Liu HL; Lin JC; Ho Y; Hsieh WC; Chen CW; et al. Molecular dynamics simulations of various coronavirus main proteinases | 0 | 0 |
| 187 | 1 | 94 | 217 2004 JOURNAL OF CLINICAL IMMUNOLOGY 24(3):213-224 Weeraratna AT; Nagel JE; De Mello-Coelho V; Taub DD Gene expression profiling: From microarrays to medicine | 0 | 0 |
| 188 | 2 | 13 | 45 2003 JOURNAL OF CLINICAL MICROBIOLOGY 41(10):4521-4524 Yam WC; Chan KH; Poon LLM; Guan Y; Yuen KY; et al. Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus | 16 | 32 |
| 189 | 4 | 12 | 218 2004 JOURNAL OF CLINICAL MICROBIOLOGY 42(3):987-991 Bressler AM; Nolte FS Preclinical evaluation of two real-time, reverse transcription-PCR assays for detection of the severe acute respiratory syndrome coronavirus | 1 | 2 |
| 190 | 3 | 17 | 219 2004 JOURNAL OF CLINICAL MICROBIOLOGY 42(4):1471-1476 Mahony JB; Petrich A; Louie L; Song XY; Chong S; et al. Performance and cost evaluation of one commercial and six in-house conventional and real-time reverse transcription-PCR assays for detection of severe acute respiratory syndrome coronavirus | 0 | 2 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 191 | 3 | 28 | 220 2004 JOURNAL OF CLINICAL MICROBIOLOGY 42(4):1570-1576 Lu LQ; Manopo I; Leung BP; Chng HH; Ling AE; et al. Immunological characterization of the spike protein of the severe acute respiratory syndrome coronavirus | 4 | 4 |
| 192 | 3 | 23 | 221 2004 JOURNAL OF CLINICAL MICROBIOLOGY 42(5):1956-1961 Thai HTC; Le MQ; Vuong CD; Parida M; Minekawa H; et al. Development and evaluation of a novel loop-mediated isothermal amplification method for rapid detection of severe acute respiratory syndrome coronavirus | 0 | 0 |
| 193 | 2 | 12 | 222 2004 JOURNAL OF CLINICAL MICROBIOLOGY 42(5):1994-1999 Hui RKH; Zeng FY; Chan CMN; Yuen KY; Peiris JSM; et al. Reverse transcriptase PCR diagnostic assay for the coronavirus associated with severe acute respiratory syndrome | 0 | 1 |
| 194 | 2 | 9 | 223 2004 JOURNAL OF CLINICAL MICROBIOLOGY 42(5):2043-2047 Drosten C; Chiu LL; Panning M; Leong HN; Preiser W; et al. Evaluation of advanced reverse transcription-PCR assays and an alternative PCR target region for detection of severe acute respiratory syndrome-associated coronavirus | 2 | 4 |
| 195 | 3 | 23 | 224 2004 JOURNAL OF CLINICAL MICROBIOLOGY 42(5):2306-2309 Woo PCY; Lau SKP; Wong BHL; Tsoi H; Fung AMY; et al. Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia | 1 | 6 |
| 196 | 2 | 9 | 225 2004 JOURNAL OF CLINICAL MICROBIOLOGY 42(5):2351-2352 Sun ZF; Meng XJ Antigenic cross-reactivity between the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus and polyclonal antisera of antigenic group I animal coronaviruses: Implication for SARS diagnosis | 3 | 3 |
| 197 | 2 | 7 | 226 2004 JOURNAL OF CLINICAL MICROBIOLOGY 42(6):2771-2773 Weidmann M; Zanotto PMDA; Weber F; Spiegel M; Brodt HR; et al. High-efficiency detection of severe acute respiratory syndrome virus genetic material | 0 | 0 |
| 198 | 6 | 38 | 227 2004 JOURNAL OF CLINICAL MICROBIOLOGY 42(7):3196-3206 Gillim-Ross L; Taylor J; Scholl DR; Ridenour J; Masters PS; et al. Discovery of novel human and animal cells infected by the severe acute respiratory syndrome coronavirus by replication-specific multiplex reverse transcription-PCR | 2 | 2 |
| 199 | 4 | 28 | 228 2004 JOURNAL OF CLINICAL MICROBIOLOGY 42(11):5309-5314 He YX; Zhou YS; Wu H; Kou ZH; Liu SW; et al. Mapping of antigenic sites on the nucleocapsid protein of the severe acute respiratory syndrome coronavirus | 0 | 0 |
| 200 | 2 | 28 | 229 2004 JOURNAL OF CLINICAL PATHOLOGY 57(3):260-265 Tse GMK; To KF; Chan PKS; Lo AWI; Ng KC; et al. Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS) | 4 | 10 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 201 | 2 | 19 | 46 2003 JOURNAL OF CLINICAL VIROLOGY 28(3):245-247 Peiris JSM Severe Acute Respiratory Syndrome (SARS) | 0 | 3 |
| 202 | 1 | 103 | 230 2004 JOURNAL OF CLINICAL VIROLOGY 29(1):2-12 Clewley JP A role for arrays in clinical virology: fact or fiction? | 1 | 2 |
| 203 | 9 | 67 | 231 2004 JOURNAL OF CLINICAL VIROLOGY 29(1):13-22 Berger A; Drosten C; Doerr HW; Sturmer M; Preiser W Severe acute respiratory syndrome (SARS) - paradigm of an emerging viral infection | 1 | 6 |
| 204 | 2 | 15 | 232 2004 JOURNAL OF CLINICAL VIROLOGY 30(4):309-312 Timani KA; Ye L; Ye LB; Zhu Y; Wu ZH; et al. Cloning, sequencing, expression, and purification of SARS-associated coronavirus nucleocapsid protein for serodiagnosis of SARS | 1 | 3 |
| 205 | 2 | 31 | 233 2004 JOURNAL OF CLINICAL VIROLOGY 31(4):239-247 Vernet G Molecular diagnostics in virology | 0 | 0 |
| 206 | 2 | 40 | 234 2004 JOURNAL OF EMERGENCY MEDICINE 26(4):415-420 Marley CT; Levsky ME; Talbot TS; Kang CS SARS and its impact on current and future Emergency Department operations | 0 | 0 |
| 207 | 3 | 32 | 381 2005 JOURNAL OF GENE MEDICINE 7(1):97-107 Shi Y; Luo HF; Jia J; Xiong J; Yang DH; et al. Antisense downregutation of SARS-CoV gene expression in Vero E6 cells | 0 | 0 |
| 208 | 3 | 50 | 47 2003 JOURNAL OF GENERAL VIROLOGY 84:2305-2315 Thiel V; Ivanov KA; Putics A; Hertzig T; Schelle B; et al. Mechanisms and enzymes involved in SARS coronavirus genome expression | 41 | 56 |
| 209 | 3 | 29 | 48 2003 JOURNAL OF GENERAL VIROLOGY 84:3291-3303 Ng ML; Tan SH; See EE; Oi EE; Ling AE Proliferative growth of SARS coronavirus in Vero E6 cells | 7 | 8 |
| 210 | 9 | 48 | 235 2004 JOURNAL OF GENERAL VIROLOGY 85:1717-1725 Hertzig T; Scandella E; Schelle B; Ziebuhr J; Siddell SG; et al. Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA | 1 | 2 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 211 | 4 | 23 | 236 2004 JOURNAL OF GENERAL VIROLOGY 85:3109-3113 Hai P; Liu YG; Han XQ; Xu YH; Jiang FG; et al. Protective humoral responses to severe acute respiratory syndrome-associated coronavirus: implications for the design of an effective protein-based vaccine | 0 | 0 |
| 212 | 11 | 27 | 382 2005 JOURNAL OF GENERAL VIROLOGY 86:211-215 Zakhartchouk AN; Viswanathan S; Mahony JB; Gauldie J; Babiuk LA Severe acute respiratory syndrome coronavirus nucleocapsid protein expressed by an adenovirus vector is phosphorylated and immunogenic in mice | 0 | 0 |
| 213 | 1 | 55 | 237 2004 JOURNAL OF IMMUNOLOGICAL METHODS 290(1-2):135-153 Visintin M; Meli GA; Cannistraci I; Cattaneo A Intracellular antibodies for proteomics | 0 | 0 |
| 214 | 7 | 18 | 383 2005 JOURNAL OF IMMUNOLOGICAL METHODS 296(1-2):37-44 Manopo I; Lu LQ; He QG; Chee LL; Chan SW; et al. Evaluation of a safe and sensitive Spike protein-based immuno fluorescence assay for the detection of antibody responses to SARS-CoV | 0 | 0 |
| 215 | 9 | 47 | 238 2004 JOURNAL OF IMMUNOLOGY 173(6):4030-4039 Glass WG; Subbarao K; Murphy B; Murphy PM Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice | 0 | 1 |
| 216 | 13 | 34 | 239 2004 JOURNAL OF IMMUNOLOGY 173(6):4050-4057 He YX; Zhou YS; Wu H; Luo BJ; Chen JM; et al. Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: Implication for developing SARS diagnostics and vaccines | 2 | 2 |
| 217 | 8 | 47 | 240 2004 JOURNAL OF IMMUNOLOGY 173(12):7602-7614 Chang YJ; Liu CYY; Chiang BL; Chao YC; Chen CC Induction of IL-8 release in lung cells via activator protein-1 by recombinant baculovirus displaying severe acute respiratory syndrome-coronavirus spike proteins: Identification of two functional regions | 0 | 0 |
| 218 | 3 | 28 | 241 2004 JOURNAL OF INFECTIOUS DISEASES 189(4):648-651 Li TS; Qiu ZF; Zhang LQ; Han Y; He W; et al. Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome | 2 | 4 |
| 219 | 3 | 19 | 242 2004 JOURNAL OF INFECTIOUS DISEASES 189(7):1164-1167 Stroher U; DiCaro A; Li Y; Strong JE; Aoki F; et al. Severe acute respiratory syndrome related coronavirus is inhibited by interferon-alpha | 4 | 12 |
| 220 | 3 | 15 | 243 2004 JOURNAL OF INFECTIOUS DISEASES 189(9):1676-1678 Zhu G; Chen HW Monophyletic relationship between severe acute respiratory syndrome coronavirus and group 2 coronaviruses | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 221 | 5 | 27 | 244 2004 JOURNAL OF INFECTIOUS DISEASES 190(1):91-98 Yao YX; Ren JY; Heinen P; Zambon M; Jones IM Cleavage and serum reactivity of the severe acute respiratory syndrome coronavirus spike protein | 1 | 1 |
| 222 | 2 | 23 | 245 2004 JOURNAL OF INFECTIOUS DISEASES 190(2):379-386 Leung DTM; Tam FCH; Ma CH; Chan PKS; Cheung JLK; et al. Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid | 3 | 4 |
| 223 | 1 | 36 | 246 2004 JOURNAL OF INFECTIOUS DISEASES 190(4):797-809 Liu IJ; Hsueh PR; Lin CT; Chiu CY; Kao CL; et al. Disease-specific B cell epitopes for serum antibodies from patients with severe acute respiratory syndrome (SARS) and serologic detection of SARS antibodies by epitope-based peptide antigens | 1 | 1 |
| 224 | 4 | 21 | 247 2004 JOURNAL OF INFECTIOUS DISEASES 190(6):1127-1131 Tong SX; Lingappa JR; Chen Q; Shu B; LaMonte AC; et al. Direct sequencing of SARS-coronavirus S and N genes from clinical specimens shows limited variation | 0 | 2 |
| 225 | 3 | 20 | 384 2005 JOURNAL OF INFECTIOUS DISEASES 191(4):492-498 Esper F; Weibel C; Ferguson D; Landry ML; Kahn JS Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children | 0 | 1 |
| 226 | 2 | 36 | 385 2005 JOURNAL OF INFECTIOUS DISEASES 191(5):755-760 Chen ZN; Mi L; Xu J; Yu JY; Wang XH; et al. Function of HAb18G/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus | 0 | 0 |
| 227 | 3 | 27 | 49 2003 JOURNAL OF MEDICAL MICROBIOLOGY 52(8):609-613 Hawkey PM; Bhagani S; Gillespie SH Severe acute respiratory syndrome (SARS): breathtaking progress | 2 | 5 |
| 228 | 1 | 17 | 248 2004 JOURNAL OF MEDICAL MICROBIOLOGY 53(5):435-438 Chen WJ; Xu ZY; Mu JS; Yang L; Gan HX; et al. Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection | 0 | 2 |
| 229 | 2 | 6 | 50 2003 JOURNAL OF MEDICAL VIROLOGY 71(3):323-331 Ng ML; Tan SH; See EE; Ooi EE; Ling AE Early events of SARS coronavirus infection in Vero cells | 6 | 8 |
| 230 | 3 | 49 | 249 2004 JOURNAL OF MEDICAL VIROLOGY 73(3):323-331 Yan HM; Xiao GF; Zhang JM; Hu YY; Yuan F; et al. SARS coronavirus induces apoptosis in Vero E6 cells | 2 | 2 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 231 | 4 | 29 | 250 2004 JOURNAL OF MEDICAL VIROLOGY 73(3):332-337 Zhang QF; Cui JM; Huan XJ; Zheng HY; Huang JH; et al. The life cycle of SARS coronavirus in Vero E6 cells | 0 | 1 |
| 232 | 4 | 27 | 251 2004 JOURNAL OF MEDICAL VIROLOGY 73(3):338-346 Huang LR; Chiu CM; Yeh SH; Huang WH; Hsueh PR; et al. Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA | 1 | 3 |
| 233 | 8 | 22 | 252 2004 JOURNAL OF MEDICAL VIROLOGY 74(1):1-7 Chan PKS; To KF; Lo AWI; Cheung JLK; Chu I; et al. Persistent infection of SARS coronavirus in colonic cells in vitro | 1 | 1 |
| 234 | 5 | 17 | 253 2004 JOURNAL OF MEDICAL VIROLOGY 74(3):369-372 Magiorkinis G; Magiorkinis E; Paraskevis D; Vandamme AM; Van Ranst M; et al. Phylogenetic analysis of the full-length SARS-CoV sequences: Evidence for phylogenetic discordance in three genomic regions | 0 | 0 |
| 235 | 6 | 17 | 254 2004 JOURNAL OF MEDICAL VIROLOGY 74(4):517-520 Chan PKS; To WK; Liu EYM; Ng TK; Tam JS; et al. Evaluation of a peptide-based enzyme immunoassay for anti-SARS coronavirus IgG antibody | 0 | 0 |
| 236 | 2 | 21 | 386 2005 JOURNAL OF MEDICAL VIROLOGY 75(3):455-462 Arden KE; Nissen MD; Sloots TP; Mackay IM New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia | 0 | 0 |
| 237 | 4 | 78 | 51 2003 JOURNAL OF MOLECULAR BIOLOGY 331(5):991-1004 Snijder EJ; Bredenbeek PJ; Dobbe JC; Thiel V; Ziebuhr J; et al. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage | 62 | 84 |
| 238 | 5 | 25 | 255 2004 JOURNAL OF MOLECULAR BIOLOGY 341(1):271-279 Zeng R; Yang RF; Shi MD; Jiang MR; Xie YH; et al. Characterization of the 3a protein of SARS-associated coronavirus in infected Vero e6 cells and SARS patients | 4 | 4 |
| 239 | 2 | 31 | 256 2004 JOURNAL OF MOLECULAR BIOLOGY 341(3):769-779 Arbely E; Khattari Z; Brotons G; Akkawi M; Salditt T; et al. A highly unusual palindromic transmembrane helical hairpin formed by SARS coronavirus E protein | 1 | 2 |
| 240 | 7 | 138 | 257 2004 JOURNAL OF NEUROVIROLOGY 10(2):75-85 Navas-Martin S; Weiss SR Coronavirus replication and pathogenesis: Implications for the recent outbreak of severe acute respiratory syndrome (SARS), and the challenge for vaccine development | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 241 | 2 | 23 | 258 2004 JOURNAL OF PATHOLOGY 202(2):157-163 To K; Tong JHM; Chan PKS; Au FWL; Chim SSC; et al. Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases | 7 | 14 |
| 242 | 6 | 31 | 259 2004 JOURNAL OF PATHOLOGY 203(2):622-630 Ding YQ; He L; Zhang QL; Huang ZX; Che XY; et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways | 4 | 6 |
| 243 | 18 | 43 | 260 2004 JOURNAL OF PATHOLOGY 203(3):740-743 To KF; Lo AW Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2) | 2 | 2 |
| 244 | 4 | 20 | 261 2004 JOURNAL OF PROTEOME RESEARCH 3(3):549-555 Zeng R; Ruan HQ; Jiang XS; Zhou H; Shi L; et al. Proteomic analysis of SARS associated coronavirus using two-dimensional liquid chromatography mass spectrometry and one-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by mass spectroemtric analysis | 1 | 1 |
| 245 | 3 | 57 | 262 2004 JOURNAL OF THE CHINESE CHEMICAL SOCIETY 51(5A):889-900 Liu HL; Lin JC; Ho Y; Hsieh WC; Chen CW; et al. Homology models and molecular dynamics simulations of main proteinase from coronavirus associated with severe acute respiratory syndrome (SARS) | 0 | 0 |
| 246 | 10 | 99 | 52 2003 JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 102(12):825-839 Hsueh PR; Yang PC Severe acute respiratory syndrome (SARS) anemerging infection of the 21st century | 0 | 1 |
| 247 | 3 | 23 | 387 2005 JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY 168:233-243 Yip PSF; Lam KF; Lau EHY; Chau PH; Tsang KW A comparison study of realtime fatality rates: severe acute respiratory syndrome in Hong Kong, Singapore, Taiwan, Toronto and Beijing, China | 0 | 0 |
| 248 | 2 | 11 | 263 2004 JOURNAL OF VIROLOGICAL METHODS 119(1):17-23 Wu QF; Xu ZY; Wei T; Zeng HP; Li JX; et al. Development of taqman RT-nested PCR system for clinical SARS-CoV detection | 0 | 0 |
| 249 | 2 | 24 | 264 2004 JOURNAL OF VIROLOGICAL METHODS 119(2):57-64 Escors D; Capiscol C; Enjuanes L Immunopurification applied to the study of virus protein composition and encapsidation | 1 | 1 |
| 250 | 2 | 36 | 265 2004 JOURNAL OF VIROLOGICAL METHODS 120(1):33-40 Houng HSH; Norwood D; Ludwig GV; Sun W; Lin MT; et al. Development and evaluation of an efficient 3 '-noncoding region based SARS coronavirus (SARS-CoV) RT-PCR assay for detection of SARS-CoV infections | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 251 | 6 | 22 | 266 2004 JOURNAL OF VIROLOGICAL METHODS 120(1):87-96 Berry JD; Jones S; Drebot MA; Andonov A; Sabara M; et al. Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus | 2 | 3 |
| 252 | 3 | 23 | 267 2004 JOURNAL OF VIROLOGICAL METHODS 121(1):85-91 Darnell MER; Subbarao K; Feinstone SM; Taylor DR Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV | 0 | 0 |
| 253 | 7 | 29 | 268 2004 JOURNAL OF VIROLOGICAL METHODS 122(1):29-36 Adachi D; Johnson G; Draker R; Ayers M; Mazzulli T; et al. Comprehensive detection and identification of human coronaviruses, including the SARS-associated coronavirus, with a single RT-PCR assay | 0 | 0 |
| 254 | 4 | 24 | 269 2004 JOURNAL OF VIROLOGICAL METHODS 122(1):105-111 Han XQ; Bartlam M; Jin YH; Liu XT; He XJ; et al. The expression of SARS-CoV M gene in P Pastoris and the diagnostic utility of the expression product | 0 | 0 |
| 255 | 3 | 40 | 270 2004 JOURNAL OF VIROLOGY 78(1):76-82 Stavrinides J; Guttman DS Mosaic evolution of the severe acute respiratory syndrome coronavirus | 14 | 21 |
| 256 | 3 | 39 | 271 2004 JOURNAL OF VIROLOGY 78(2):669-682 Goebel SJ; Hsue B; Dombrowski TF; Masters PS Characterization of the RNA components of a putative molecular switch in the 3 ' untranslated region of the murine coronavirus genome | 3 | 6 |
| 257 | 2 | 27 | 272 2004 JOURNAL OF VIROLOGY 78(9):4552-4560 Babcock GJ; Esshaki DJ; Thomas WD; Ambrosino DM Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor | 12 | 15 |
| 258 | 2 | 38 | 273 2004 JOURNAL OF VIROLOGY 78(9):4638-4645 Kim TW; Lee JH; Hung CF; Peng SW; Roden R; et al. Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus | 8 | 13 |
| 259 | 3 | 47 | 274 2004 JOURNAL OF VIROLOGY 78(10):5486-5490 Turner BC; Hemmila EM; Beauchemin N; Holmes KV Receptor-dependent coronavirus infection of dendritic cells | 0 | 1 |
| 260 | 3 | 31 | 275 2004 JOURNAL OF VIROLOGY 78(11):5612-5618 Wang YD; Sin WYF; Xu GB; Yang HH; Wong TY; et al. T-cell epitopes in Severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS | 2 | 3 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 261 | 7 | 92 | 276 2004 JOURNAL OF VIROLOGY 78(11):5619-5632 Ivanov KA; Thiel V; Dobbe JC; van der Meer Y; Snijder EJ; et al. Multiple enzymatic activities associated with Severe acute respiratory syndrome coronavirus helicase | 5 | 12 |
| 262 | 5 | 46 | 277 2004 JOURNAL OF VIROLOGY 78(11):5642-5650 Yang ZY; Huang Y; Ganesh L; Leung K; Kong WP; et al. pH-dependent entry of Severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN | 9 | 18 |
| 263 | 2 | 82 | 278 2004 JOURNAL OF VIROLOGY 78(11):5891-5899 Neuman BW; Stein DA; Kroeker AD; Paulino AD; Moulton HM; et al. Antisense morpholino-oligomers directed against the 5 ' end of the genome inhibit coronavirus proliferation and growth | 0 | 2 |
| 264 | 8 | 75 | 279 2004 JOURNAL OF VIROLOGY 78(12):6134-6142 Hofmann H; Hattermann K; Marzi A; Gramberg T; Geier M; et al. S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients | 5 | 6 |
| 265 | 5 | 60 | 280 2004 JOURNAL OF VIROLOGY 78(13):6723-6734 Tan YJ; Teng E; Shen S; Tan THP; Goh PY; et al. A novel severe acute respiratory syndrome coronavirus protein U274, is transported to the cell surface and undergoes endocytosis | 7 | 8 |
| 266 | 6 | 47 | 281 2004 JOURNAL OF VIROLOGY 78(13):6938-6945 Zhang H; Wang GW; Li H; Nie YC; Shi XL; et al. Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies | 6 | 9 |
| 267 | 4 | 22 | 282 2004 JOURNAL OF VIROLOGY 78(13):7217-7226 Zhou T; Wang H; Luo DL; Rowe T; Wang Z; et al. An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies | 5 | 7 |
| 268 | 6 | 28 | 283 2004 JOURNAL OF VIROLOGY 78(14):7311-7318 Fielding BC; Tan YJ; Shuo S; Tan THP; Ooi EE; et al. Characterization of a unique group-specific protein (U122) of the severe acute respiratory syndrome coronavirus | 3 | 4 |
| 269 | 5 | 32 | 284 2004 JOURNAL OF VIROLOGY 78(14):7523-7527 Wang Z; Ren LL; Zhao XG; Hung T; Meng A; et al. Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells | 1 | 2 |
| 270 | 4 | 31 | 285 2004 JOURNAL OF VIROLOGY 78(14):7846-7851 Goebel SJ; Taylor J; Masters PS The 3 ' cis-acting genomic replication element of the severe acute respiratory syndrome coronavirus can function in the murine coronavirus genome | 0 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 271 | 8 | 23 | 286 2004 JOURNAL OF VIROLOGY 78(15):7863-7866 Gorbalenya AE; Snijder EJ; Spaan WJM Severe acute respiratory syndrome coronavirus phylogeny: toward consensus | 3 | 5 |
| 272 | 3 | 46 | 287 2004 JOURNAL OF VIROLOGY 78(17):9007-9015 Giroglou T; Cinatl J; Rabenau H; Drosten C; Schwalbe H; et al. Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein | 0 | 1 |
| 273 | 2 | 69 | 288 2004 JOURNAL OF VIROLOGY 78(17):9073-9083 Schickli JH; Thackray LB; Sawicki SG; Holmes KV The N-terminal region of the murine coronavirus spike glycoprotein is associated with the extended host range of viruses from persistently infected murine cells | 0 | 0 |
| 274 | 8 | 39 | 289 2004 JOURNAL OF VIROLOGY 78(18):9977-9986 Prentice E; McAuliffe J; Lu XT; Subbarao K; Denison MR Identification and characterization of severe acute respiratory syndrome coronavirus replicase proteins | 1 | 1 |
| 275 | 8 | 36 | 290 2004 JOURNAL OF VIROLOGY 78(19):10328-10335 Song HC; Seo MY; Stadler K; Yoo BJ; Choo QL; et al. Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein | 1 | 1 |
| 276 | 6 | 26 | 291 2004 JOURNAL OF VIROLOGY 78(19):10628-10635 Moore MJ; Dorfman T; Li WH; Wong SK; Li YH; et al. Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2 | 0 | 0 |
| 277 | 4 | 55 | 292 2004 JOURNAL OF VIROLOGY 78(20):11334-11339 Yi L; Li ZQ; Yuan KH; Qu XX; Chen J; et al. Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells | 0 | 0 |
| 278 | 5 | 32 | 293 2004 JOURNAL OF VIROLOGY 78(22):12218-12224 Bhardwaj K; Guarino L; Kao CC The severe acute respiratory syndrome coronavirus Nsp15 protein is an endoribonuclease that prefers manganese as a cofactor | 0 | 0 |
| 279 | 3 | 35 | 294 2004 JOURNAL OF VIROLOGY 78(22):12557-12565 Huang Y; Yang ZY; Kong WP; Nabel GJ Generation of synthetic severe acute respiratory syndrome coronavirus pseudoparticles: Implications for assembly and vaccine production | 0 | 0 |
| 280 | 8 | 20 | 295 2004 JOURNAL OF VIROLOGY 78(22):12672-12676 Weingartl H; Czub M; Czub S; Neufeld J; Marszal P; et al. Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 281 | 4 | 39 | 296 2004 JOURNAL OF VIROLOGY 78(22):12683-12688 Almazan F; Galan C; Enjuanes L The nucleoprotein is required for efficient coronavirus genome replication | 0 | 0 |
| 282 | 12 | 35 | 297 2004 JOURNAL OF VIROLOGY 78(24):13600-13612 Harcourt BH; Jukneliene D; Kanjanahaluethai A; Bechill J; Severson KM; et al. Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity | 0 | 0 |
| 283 | 10 | 33 | 298 2004 JOURNAL OF VIROLOGY 78(24):14043-14047 Tan YJ; Fielding BC; Goh PY; Shen S; Tan THP; et al. Overexpression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway | 1 | 1 |
| 284 | 6 | 29 | 299 2004 JOURNAL OF VIROLOGY 78(24):14057-14061 Parera M; Clotet B; Martinez MA Genetic screen for monitoring severe acute respiratory syndrome coronavirus 3C-like protease | 0 | 0 |
| 285 | 11 | 51 | 388 2005 JOURNAL OF VIROLOGY 79(2):884-895 Woo PCY; Lau SKP; Chu CM; Chan KH; Tsoi HW; et al. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia | 0 | 0 |
| 286 | 7 | 50 | 389 2005 JOURNAL OF VIROLOGY 79(3):1743-1752 Guillen J; Perez-Berna AJ; Moreno MR; Villalain J Identification of the membrane-active regions of the severe acute respiratory syndrome coronavirus spike membrane glycoprotein using a 16/18-mer peptide scan: Implications for the viral fusion mechanism | 0 | 0 |
| 287 | 12 | 29 | 390 2005 JOURNAL OF VIROLOGY 79(3):1906-1910 Wang SX; Chou THW; Sakhatskyy PV; Huang S; Lawrence JM; et al. Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system | 0 | 0 |
| 288 | 5 | 34 | 391 2005 JOURNAL OF VIROLOGY 79(3):1966-1969 Akerstrom S; Mousavi-Jazi M; Klingstrom J; Leijon M; Lundkvist A; et al. Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus | 0 | 0 |
| 289 | 6 | 22 | 392 2005 JOURNAL OF VIROLOGY 79(4):2620-2625 Wu DL; Tu CC; Xin C; Xuan H; Meng QW; et al. Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates | 0 | 0 |
| 290 | 8 | 33 | 393 2005 JOURNAL OF VIROLOGY 79(5):3182-3186 Ito N; Mossel EC; Narayanan K; Popov VL; Huang C; et al. Severe acute respiratory syndrome coronavirus 3a protein is a viral structural protein | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 291 | 2 | 18 | 394 2005 KIDNEY INTERNATIONAL 67(2):698-705 Chu KH; Tsang WK; Tang CS; Lam MF; Lai FM; et al. Acute renal impairment in coronavirus-associated severe acute respiratory syndrome | 0 | 0 |
| 292 | 3 | 17 | 300 2004 LABORATORY INVESTIGATION 84(9):1085-1091 Juang JL; Chen TC; Jiang SS; Hsiung CA; Chen WC; et al. Coupling multiplex RT-PCR to a gene chip assay for sensitive and semiquantitative detection of severe acute respiratory syndrome-coronavirus | 0 | 1 |
| 293 | 2 | 20 | 53 2003 LANCET 362(9383):570-572 Ng SKC Possible role of an animal vector in the SARS outbreak at Amoy Gardens | 12 | 21 |
| 294 | 2 | 4 | 54 2003 LANCET 362(9398):1807-1808 Chim SSC; Tsui SKW; Chan KCA; Au TCC; Hung ECW; et al. Genomic characterisation of the severe acute respiratory syndrome coronavirus of Amoy Gardens outbreak in Hong Kong | 8 | 12 |
| 295 | 1 | 5 | 55 2003 LANCET 362(9399):1895-1896 Gao WT; Tamin A; Soloff A; D'Aiuto L; Nwanegbo E; et al. Effects of a SARS-associated coronavirus vaccine in monkeys | 19 | 26 |
| 296 | 5 | 27 | 301 2004 LANCET 363(9403):99-104 Guan Y; Peiris JSM; Zheng B; Poon LLM; Chan KH; et al. Molecular epidemiology of the novel coronavirus that causes severe acute respiratory syndrome | 8 | 13 |
| 297 | 2 | 27 | 302 2004 LANCET 363(9412):841-845 Woo PCY; Lau SKP; Tsoi HW; Chan KH; Wong BHL; et al. Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia | 3 | 11 |
| 298 | 3 | 50 | 303 2004 LANCET 363(9413):938-947 Liu SW; Xiao GF; Chen YB; He YX; Niu JK; et al. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors | 17 | 22 |
| 299 | 2 | 29 | 304 2004 LANCET 363(9427):2122-2127 Bukreyev A; Lamirande EW; Buchholz UJ; Vogel LN; Elkins WR; et al. Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS | 6 | 12 |
| 300 | 24 | 89 | 305 2004 LANCET INFECTIOUS DISEASES 4(11):663-671 Poon LLM; Guan Y; Nicholls JM; Yuen KY; Peiris JSM The aetiology, origins, and diagnosis of severe acute respiratory syndrome | 1 | 1 |
Page 1: 1 2
Generated by: HistCite 2004.12.21